This would include renal oncocytoma, eosinophilic variant of chromophobe RCC, succinate dehydrogenase (SDH)-deficient RCC, MiTF translocation RCC (particularly TFEB), and epithelioid angiomyolipoma (AML). This evidence concerns the gene SDHB and acute myeloid leukemia.